Key result
Complete surgical resection of a huge primary dedifferentiated pancreatic liposarcoma in a young female resulted in no relapse at 26 months of follow-up.
Why the study?
Pancreatic liposarcoma is a rare tumor, with few cases reported in the literature.
Case Report (n=1)
Complete resection of a rare primary dedifferentiated pancreatic liposarcoma resulted in no relapse at 26 months in a young female.
May prompt consideration of rare sarcomas in pancreatic masses; leaves open optimal management strategies.
BACKGROUND: Pancreatic liposarcoma is a rare tumor. According to a literature review, the patient described in this study is the seventh case of pancreatic liposarcoma reported in the English literature and the third case of dedifferentiated liposarcoma. Furthermore, this case had the largest primary tumor volume, and a primary pancreatic liposarcoma was diagnosed based on sufficient evidence. CASE SUMMARY: gene amplification, the tumor was diagnosed as a dedifferentiated liposarcoma. The patient was treated with surgery but declined postoperative chemotherapy. She was well at the 26-mo follow-up, and no relapse was observed. CONCLUSION: Pancreatic liposarcoma has a low incidence. Chemotherapy should be included in the treatment regimens. Complete resection is the only effective treatment.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2019) conducted a case report in Primary dedifferentiated pancreatic liposarcoma (n=1). Surgery (complete resection) was evaluated on Relapse. Complete surgical resection of a huge primary dedifferentiated pancreatic liposarcoma in a young female resulted in no relapse at 26 months of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: